Key Facts A study of nearly 1,700 patients who either used semaglutidethe active ingredient in Ozempic and Wegovyor another drug for treating Type 2 diabetes or obesity found a possible link between semaglutide and nonarteritic anterior ischemic optic neuropathy (NAION), researchers said
Although the image of the vial states that it is for Research Use Only, the products description says: If you are looking for medication that can help you manage your diabetes or obesity, semaglutide is a great option. According to the products description, the business selling the product is Revitalized Health Research, located in Idaho
Survodutide Survodutide is a dual glucagon and GLP-1 receptor agonist developed by Boehringer Ingelheim and Zealand Pharma, investigated for obesity, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis (MASH)
Were committed to helping you achieve your health goals and navigate the path toward improved wellness
This phenomenon has the potential to perpetuate unrealistic beauty standards and contribute to the misuse of semaglutide